Cancer data analysis using competitive ensemble machine learning techniques

Cancer stands as a formidable adversary on the global stage, claiming a significant number of lives each year. Yet, amidst this sobering reality, the importance of early detection cannot be overstated.

Vigilant screenings, educational initiatives, and advancements in diagnostic technologies have emerged as crucial allies in our fight against this disease, enabling the identification of cancer at its most treatable stages and bolstering the prospects of successful intervention. In this paper, we embark on a transformative journey in cancer data analysis, harnessing the power of competitive ensemble machine learning techniques. Through meticulous feature selection, hyperparameter tuning, and data preprocessing, our methodology seeks to transcend the limitations of individual models, striving for heightened accuracy and nuanced insights.Three dataset used in the work is taken from UCI Machine Learning Repository.

Our experimental findings underscore the efficacy of this approach, with accuracy rates reaching impressive levels: 99% for the Breast Cancer dataset, 90% for the Breast Coimbra dataset, and 96% for the Cervical Cancer dataset. These results, achieved through a competitive mode, mark a notable improvement over existing classifications.

The significance of our work lies in its potential to equip healthcare professionals with a robust model, one capable of facilitating early detection, accurate prognosis, and personalized treatment strategies. By enhancing the effectiveness of cancer management, we aspire to chart a path toward improved patient outcomes and a brighter future in our collective battle against this relentless foe.